US2019275100A1PendingUtilityA1
Application of longhu rendan in preparing medicament for preventing and/or treating liver fibrosis
Assignee: SHANGHAI ZHONGHUA PHARMACEUTICAL CO LTDPriority: May 2, 2017Filed: Apr 23, 2018Published: Sep 12, 2019
Est. expiryMay 2, 2037(~10.8 yrs left)· nominal 20-yr term from priority
A61K 47/34A61K 31/045A61K 47/12A61K 47/02A61K 36/54A61K 36/9064A61P 1/16A61K 36/534A61K 36/67A61K 36/28A61K 47/36A61K 36/9068A61K 36/79A61K 36/899A61K 36/61A61K 36/484A61K 36/285A61K 36/57A61K 36/48A61K 9/2059
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An application of Longhu Rendan in preparing a medicament for preventing and/or treating liver fibrosis The Longhu Rendan has significant effect in improving liver fibrosis, and its effect in anti-liver fibrosis and liver protection is equivalent to those of a positive drug silybin.
Claims
exact text as granted — not AI-modified1 . A method of preparing a medicament for preventing and/or treating liver fibrosis, comprising an application of Longhu Rendan.
2 . The method of claim 1 , wherein the Longhu Rendan comprises following components in parts by mass: 32 g to 48 g of menthol, 24 g to 36 g of borneol, 20 g to 30 g of clove, 20 g to 30 g of fructus amomi, 12 g to 18 g of star anise, 32 g to 48 g of cinnamon, 12 g to 18 g of pepper, 12 g to 18 g of costus root, 20 g to 30 g of dried ginger, 160 g to 240 g of catechu, 291.28 g to 436.92 g of licorice, 144 g to 216 g of glutinous rice flour, 4 g to 6 g of sodium benzoate, 11.6 g to 17.4 g red iron oxide, 0.08 ml to 0.12 ml of dimethicone, 0.16 g to 0.24 g of graphite, 0.16 g to 0.24 g of talc, and 3.16 g to 4.74 g of dextrin in every 1000 g.
3 . The method of claim 1 , wherein a formulation of the Longhu Rendan comprises tablets, powders, granules, pills, and capsules.
4 . The method of claim 1 , wherein an effective dose of the Longhu Rendan is 100 mg/kg to 200 mg/kg.
5 . The method of claim 2 , wherein a formulation of the Longhu Rendan comprises tablets, powders, granules, pills, and capsules.Join the waitlist — get patent alerts
Track US2019275100A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.